Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

J Yin, L Wang, Y Wang, H Shen, X Wang… - OncoTargets and …, 2019 - Taylor & Francis
Background Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …
被引用次数：70 相关文章

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway.

J Yin, L Wang, Y Wang, H Shen… - OncoTargets & …, 2019 - search.ebscohost.com
Background: Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway.

J Yin, L Wang, Y Wang, H Shen, X Wang… - Oncotargets and …, 2019 - europepmc.org
Background: Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …
[HTML] nih.gov

[HTML][HTML] Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

J Yin, L Wang, Y Wang, H Shen, X Wang… - OncoTargets and …, 2019 - ncbi.nlm.nih.gov
Background: Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …

[引用][C] Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

J Yin, L Wang, Y Wang, H Shen, X Wang… - OncoTargets and …, 2019 - cir.nii.ac.jp
<p>Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of
TGF-β/Smad2/3 signaling pathway</p> | CiNii Research CiNii 国立情報学研究所 学術情報 …

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

J Yin, L Wang, Y Wang, H Shen, X Wang… - OncoTargets and …, 2019 - dovepress.com
Background: Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-[beta]/Smad2/3 signaling pathway.

J Yin, L Wang, Y Wang, H Shen, X Wang… - OncoTargets and …, 2019 - go.gale.com
The 2018 American Cancer Society (ACS) report shows that there are more than 1 million
new cases of colorectal cancer (CRC) annually, with a mortality rate close to 33%.(1) The …

Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway

J Yin, L Wang, Y Wang, H Shen… - OncoTargets and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background: Oxaliplatin (OXA) resistance is a main obstacle to the chemotherapy of
colorectal cancer (CRC). Epithelial-mesenchymal transition (EMT), which is mainly …